Journal: Frontiers in Oncology
Article Title: Ferroptosis-related gene signature-based subtype identification of triple-negative breast cancer to prioritize treatment strategies
doi: 10.3389/fonc.2025.1541119
Figure Lengend Snippet: SOCS1 and NOX4 were correlated with the TME reshape in TNBC. (A–E) Pearson’s correlation analysis of the mRNA expression of SOCS1 and immune checkpoints (PD-1, PD-L1, CTLA-4, LAG3, and TIM3). (F–H) Pearson’s correlation analysis of the mRNA expression of NOX4 and immune checkpoints (PD-1, IDO1, and LAG3). (I) IHC detected the expression of SOCS1, NOX4, PD-1, and CD3 in two immune phenotypes of TNBC according to the spatial distribution of CD8 + T cells. Representative co-stained images are shown, and the scale bar corresponds to 500 μm. (J) The expression of SOCS1, NOX4, PD-1, and CD3 in two phenotypes of TNBC detected by four-color IF. Representative co-stained images are displayed, and the scale bar corresponds to 20 μm. (K) The expression levels of the SOCS1 gene across 11 TNBC cell lines using the DepMap portal ( https://depmap.org/portal ). (L) The knockdown efficiency of SOCS1 in MDA-MB-231 cells. (M) Cell viability in MDA-MB-231 cells (either control or shSOCS1) treated with RSL3 was assessed using the CCK-8 assay. **p < 0.01. TME, tumor microenvironment; TNBC, triple-negative breast cancer; IHC, immunohistochemical; IF, immunofluorescence.
Article Snippet: The knockdown efficiency was evaluated by Western blotting analysis using an antibody against human SOCS1 (Cat# 55313, Cell Signaling Technology, Inc., Danvers, MA, USA).
Techniques: Expressing, Staining, Knockdown, Control, CCK-8 Assay, Immunohistochemical staining, Immunofluorescence